NKGen Biotech (NKGN) Institutional Ownership $0.64 +0.07 (+13.25%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for NKGen Biotech (NYSE:NKGN)CurrentInstitutional OwnershipPercentage76.17%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.60MNumber ofInstitutional Sellers(last 12 months)0 Get NKGN Insider Trade Alerts Want to know when executives and insiders are buying or selling NKGen Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! NKGen Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Polar Asset Management Partners Inc.1,181,872$447K0.0%+9.4%3.342% 10/22/2024 Sequoia Financial Advisors LLC69,000$26K0.0%+273.0%0.268% 5/1/2024 Sequoia Financial Advisors LLC16,000$30K0.0%N/A0.070% 3/14/2024 University of Chicago550,000$1.51M2.1%N/A2.513% (Data available from 1/1/2016 forward) NKGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NKGN shares? During the previous two years, the following institutional investors and hedge funds held shares of NKGen Biotech shares: University of Chicago ($1.51M), and Polar Asset Management Partners Inc. ($447K), Sequoia Financial Advisors LLC ($26K).Learn more on NKGN's institutional investors. What percentage of NKGen Biotech stock is owned by institutional investors? 76.17% of NKGen Biotech stock is owned by institutional investors. Learn more on NKGN's institutional investor holdings. Which institutional investors have been buying NKGen Biotech stock? The following institutional investors have purchased NKGen Biotech stock in the last 24 months: University of Chicago ($550K), Polar Asset Management Partners Inc. ($101.87K), and Sequoia Financial Advisors LLC ($66.50K). How much institutional buying is happening at NKGen Biotech? Institutional investors have bought a total of 718,372 shares in the last 24 months. This purchase volume represents approximately $1.60M in transactions. Related Companies InterCure Major Shareholders Oncolytics Biotech Major Shareholders Cue Biopharma Major Shareholders BeyondSpring Major Shareholders VolitionRx Major Shareholders Atara Biotherapeutics Major Shareholders Connect Biopharma Major Shareholders Spero Therapeutics Major Shareholders Aadi Bioscience Major Shareholders Mural Oncology Major Shareholders This page (NYSE:NKGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NKGN Stock Alerts